HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 89 filers reported holding HARPOON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $66,000 | -59.0% | 68,115 | -19.1% | 0.00% | – |
| Q2 2022 | $161,000 | -68.6% | 84,234 | -18.4% | 0.00% | – |
| Q1 2022 | $513,000 | -1.2% | 103,267 | +50.3% | 0.00% | – |
| Q4 2021 | $519,000 | -3.2% | 68,689 | +1.2% | 0.00% | – |
| Q3 2021 | $536,000 | -59.1% | 67,871 | -28.2% | 0.00% | – |
| Q2 2021 | $1,310,000 | +113.0% | 94,484 | +221.5% | 0.00% | – |
| Q1 2021 | $615,000 | +20.6% | 29,387 | -4.2% | 0.00% | – |
| Q4 2020 | $510,000 | -4.1% | 30,687 | -2.2% | 0.00% | – |
| Q3 2020 | $532,000 | +50.3% | 31,380 | +46.9% | 0.00% | – |
| Q2 2020 | $354,000 | – | 21,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $24,938,000 | 7.19% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $24,738,000 | 5.73% |
| MPM BioImpact LLC | 3,196,707 | $25,254,000 | 3.92% |
| Affinity Asset Advisors, LLC | 250,000 | $1,975,000 | 0.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 215,000 | $1,696,000 | 0.41% |
| Orbimed Advisors | 2,611,308 | $20,629,000 | 0.23% |
| DAFNA Capital Management LLC | 105,163 | $831,000 | 0.22% |
| Avidity Partners Management LP | 1,190,600 | $9,406,000 | 0.21% |
| Artal Group S.A. | 1,000,000 | $7,900,000 | 0.18% |
| Cormorant Asset Management, LP | 540,600 | $4,271,000 | 0.17% |